Jasmine C

2023 Approvals

FDA Approves Jaypirca for Mantle Cell Lymphoma Treatment on January 20, 2023

What is Jaypirca prescribed for? Jaypirca is prescribed to treat relapsed or refractory mantle cell lymphoma in adults who have had at least two lines of systemic therapy, including a BTK inhibitor. What is the name of the drug and what does it do? The name of the drug is

2023 Approvals

Zurzuvae approved for treatment of postpartum depression on August 04, 2023

What is Zurzuvae prescribed for? Zurzuvae is prescribed to treat postpartum depression in adults. What is the name of the drug and what does it do? Zurzuvae, pronounced ZUR-zoo-vay, (generic name: zuranolone) is a medication approved for treating postpartum depression (PPD) in adults. It belongs to a class of drugs

See all